PREDNISOLONE Side Effects

7023324-0 | Cerebrovascular Accident
on Sep 16, 2010 Female patient from UNITED KINGDOM , 80 years of age, was diagnosed with temporal arteritis and was treated with Prednisolone (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrovascular accident. Prednisolone dosage: . During the same period patient was treated with METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), BENDROFLUMETHIAZIDE (View Bendroflumethiazide Review and Bendroflumethiazide Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ).

7022515-2 | Cerebrovascular Accident
Patient was taking Prednisolone (View Usage). Patient had the following side effects: cerebrovascular accident on Sep 15, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 61 years of age, was diagnosed with temporal arteritis and. Prednisolone dosage: . During the same period patient was treated with ASPIRINE (View Aspirine Review and Aspirine Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

7018752-3 | Biliary Fibrosis, Disease Recurrence, Hepatic Lesion, Hepatic Neoplasm Malignant Recurrent, Hepatitis C, Inflammation, Liver Transplant, Tumour Invasion
Adverse event was reported on Sep 22, 2010 by a Male patient taking Prednisolone (View Usage) (Dosage: ) was diagnosed with renal transplant and. Location: , 46 years of age, After Prednisolone was administered, patient had the following side effects: biliary fibrosis, disease recurrence, hepatic lesion, hepatic neoplasm malignant recurrent, hepatitis c (What is hepatitis c?), inflammation, liver transplant (What is liver transplant?), tumour invasion. During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ).

7012426-0 | Chest Discomfort, Erythema, Palatal Oedema
on Sep 22, 2010 Female patient from FRANCE , 68 years of age, was treated with Prednisolone (View Usage). Patient experienced the following unwanted or unexpected effects: chest discomfort, erythema, palatal oedema. Prednisolone dosage: . During the same period patient was treated with NASACORT (View Nasacort Review and Nasacort Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), AMOXICILLIN AND CLAVULANATE POTASSIUM (View Amoxicillin And Clavulanate Potassium Review and Amoxicillin And Clavulanate Potassium Label ), FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE (View Fosinopril Sodium And Hydrochlorothiazide Review and Fosinopril Sodium And Hydrochlorothiazide Label ), TANAKAN (View Tanakan Review and Tanakan Label ), AZOPT (View Azopt Review and Azopt Label ). Patient was hospitalized.


7003453-8 | Cerebral Haemorrhage, Disseminated Intravascular Coagulation, Infection, Multi-organ Failure, Pyrexia, Stress Cardiomyopathy
on Sep 07, 2010 Female patient from JAPAN , 67 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Prednisolone (View Usage). Patient had the following side effects: cerebral haemorrhage, disseminated intravascular coagulation, infection (What is infection?), multi-organ failure, pyrexia, stress cardiomyopathy. Prednisolone dosage: Unk. During the same period patient was treated with DEXAMETHASONE (WATSON LABORATORIES) (Unk) (View Dexamethasone (watson Laboratories) Review and Dexamethasone (watson Laboratories) Label ), MELPHALAN HYDROCHLORIDE (Unk) (View Melphalan Hydrochloride Review and Melphalan Hydrochloride Label ), VINCRISTINE (Unk) (View Vincristine Review and Vincristine Label ), ADRIAMYCIN PFS (Unk) (View Adriamycin Pfs Review and Adriamycin Pfs Label ). Patient was hospitalized.

7003340-5 | Renal Failure Acute, Tumour Lysis Syndrome
Patient was taking Prednisolone (View Usage). After Prednisolone was administered, patient had the following side effects: renal failure acute, tumour lysis syndrome on Sep 07, 2010 from TURKEY Additional patient health information: Male patient , 19 years of age, was diagnosed with acute lymphocytic leukaemia and. Prednisolone dosage: 64 Mg, Daily. During the same period patient was treated with CYCLOPHOSPHAMIDE (1 G, Daily) (View Cyclophosphamide Review and Cyclophosphamide Label ). Patient was hospitalized.

6988449-4 | C-reactive Protein Increased, Episcleritis, Headache, Hypoglossal Nerve Paralysis, Optic Atrophy, Pachymeningitis, Pruritus, Pupillary Reflex Impaired
Adverse event was reported on Sep 08, 2010 by a Female patient taking Prednisolone (View Usage) (Dosage: ) was diagnosed with microscopic polyangiitis and. Location: , 68 years of age, Patient experienced the following unwanted or unexpected effects: c-reactive protein increased, episcleritis, headache (What is headache?), hypoglossal nerve paralysis, optic atrophy, pachymeningitis, pruritus, pupillary reflex impaired. Patient was hospitalized and became disabled.

6988357-9 | Abdominal Pain, Abdominal Symptom, Burkitt's Lymphoma, Cardiovascular Disorder, Complications Of Transplanted Heart, Device Related Sepsis, Epstein-barr Virus Associated Lymphoproliferative Disorder, Epstein-barr Virus Infection, Lymphadenopathy
on Aug 19, 2010 Male patient from UNITED KINGDOM , 13 years of age, was diagnosed with heart transplant (What is heart transplant?), epstein-barr virus associated lymphoproliferative disorder and was treated with Prednisolone (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), abdominal symptom, burkitt's lymphoma, cardiovascular disorder, complications of transplanted heart, device related sepsis, epstein-barr virus associated lymphoproliferative disorder, epstein-barr virus infection, lymphadenopathy. Prednisolone dosage: . During the same period patient was treated with TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), (RITUXIMAB) (View (rituximab) Review and (rituximab) Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), DEXRAZOXANE (View Dexrazoxane Review and Dexrazoxane Label ), THIOGUANINE (View Thioguanine Review and Thioguanine Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ).

6981595-0 | Epstein-barr Virus Associated Lymphoproliferative Disorder, Gastrointestinal Ulcer, Hepatosplenomegaly, Lymphadenopathy
on Aug 31, 2010 Male patient from UNITED KINGDOM , child 10 years of age, was diagnosed with lymphoproliferative disorder and was treated with Prednisolone (View Usage). After Prednisolone was administered, patient had the following side effects: epstein-barr virus associated lymphoproliferative disorder, gastrointestinal ulcer, hepatosplenomegaly, lymphadenopathy. Prednisolone dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ). Patient was hospitalized.

6981046-6 | Cerebrovascular Accident, Hemiparesis
Patient was taking Prednisolone (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrovascular accident, hemiparesis on Sep 06, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 80 years of age, was diagnosed with temporal arteritis and. Prednisolone dosage: .

6981045-4 | Cerebrovascular Accident
Adverse event was reported on Sep 06, 2010 by a Male patient taking Prednisolone (View Usage) (Dosage: ) was diagnosed with temporal arteritis and. Location: UNITED KINGDOM , 61 years of age, Patient had the following side effects: cerebrovascular accident.

6979669-3 | Pneumonia, Systemic Candida
on Aug 24, 2010 Female patient from JAPAN , 78 years of age, was diagnosed with t-cell lymphoma and was treated with Prednisolone (View Usage). After Prednisolone was administered, patient had the following side effects: pneumonia (What is pneumonia?), systemic candida. Prednisolone dosage: 20 Mg, Qd, Oral. During the same period patient was treated with ETRETINATE (ETRETINATE) (30-40 Mg Qd, Oral) (View Etretinate (etretinate) Review and Etretinate (etretinate) Label ).

6973721-4 | Hepatitis B
on Aug 30, 2010 Female patient from TURKEY , 57 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Prednisolone (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis b (What is hepatitis b?). Prednisolone dosage: 60 Mg/m2, Cyclic, Days 1-28. During the same period patient was treated with VINCRISTINE (1.5 Mg/m2, Cyclic, Days 1, 8, 15, 22) (View Vincristine Review and Vincristine Label ), DAUNORUBICIN HYDROCHLORIDE (25 Mg/m2, Cyclic, Days 1, 8, 15, 22) (View Daunorubicin Hydrochloride Review and Daunorubicin Hydrochloride Label ), CYCLOPHOSPHAMIDE (650 Mg/m2, Cyclic, Days 29, 43, 57) (View Cyclophosphamide Review and Cyclophosphamide Label ), CYTARABINE (75 Mg/m2, Cyclic, Days 31-34, 38-41, 45-48, 52-57) (View Cytarabine Review and Cytarabine Label ), METHOTREXATE (12 Mg, Cyclic, Days 1, 8, 15, 22) (View Methotrexate Review and Methotrexate Label ), MITOXANTRONE (12 Mg/m2, Cyclic, Days 1-3) (View Mitoxantrone Review and Mitoxantrone Label ), ETOPOSIDE (200 Mg/m2, Cyclic, Days 8-10) (View Etoposide Review and Etoposide Label ).

6971205-0 | Extradural Abscess, Haemorrhagic Stroke, Pneumonia
Patient was taking Prednisolone (View Usage). Patient had the following side effects: extradural abscess, haemorrhagic stroke, pneumonia (What is pneumonia?) on Aug 25, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 52 years of age, was diagnosed with pemphigus (What is pemphigus?) and. Prednisolone dosage: . During the same period patient was treated with AZATHIOPRINE (150 Mg, Daily) (View Azathioprine Review and Azathioprine Label ). Patient was hospitalized.

6963800-X | Coronary Artery Thrombosis
Adverse event was reported on Aug 27, 2010 by a Female patient taking Prednisolone (View Usage) (Dosage: 50 Mg Daily, Taper To 40 Mg Daily) was diagnosed with systemic lupus erythematosus and. Location: JAPAN , 24 years of age, After Prednisolone was administered, patient had the following side effects: coronary artery thrombosis. Patient was hospitalized.

6963057-X | Abdominal Pain, Burkitt's Lymphoma, Device Related Infection, Device Related Sepsis, Epstein-barr Virus Associated Lymphoproliferative Disorder, Mass, Muscle Contractions Involuntary, Pneumocystis Jiroveci Pneumonia, Progressive Multifocal Leukoencephalopathy
on Aug 19, 2010 Male patient from UNITED KINGDOM , 13 years of age, was diagnosed with heart transplant (What is heart transplant?), epstein-barr virus associated lymphoproliferative disorder and was treated with Prednisolone (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), burkitt's lymphoma, device related infection, device related sepsis, epstein-barr virus associated lymphoproliferative disorder, mass, muscle contractions involuntary, pneumocystis jiroveci pneumonia, progressive multifocal leukoencephalopathy. Prednisolone dosage: 2000 Mg/m2. During the same period patient was treated with TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), VINCRISTINE (6 Mg/m2) (View Vincristine Review and Vincristine Label ), RITUXAN (375 Mg/m2) (View Rituxan Review and Rituxan Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), DEXRAZOXANE (View Dexrazoxane Review and Dexrazoxane Label ), THIOGUANINE (750 Mg/m2) (View Thioguanine Review and Thioguanine Label ), CYTARABINE (1000 Mg/m2) (View Cytarabine Review and Cytarabine Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ).

6961093-0 | Reversible Posterior Leukoencephalopathy Syndrome
on Aug 25, 2010 Female patient from UNITED KINGDOM , 60 years of age, was treated with Prednisolone (View Usage). Patient had the following side effects: reversible posterior leukoencephalopathy syndrome. Prednisolone dosage: Unk. During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ).

6956807-X | Extradural Abscess, Haemorrhagic Stroke, Peripheral Ischaemia, Pneumonia, Tinnitus, Vertigo, Visual Impairment
Patient was taking Prednisolone (View Usage). After Prednisolone was administered, patient had the following side effects: extradural abscess, haemorrhagic stroke, peripheral ischaemia, pneumonia (What is pneumonia?), tinnitus (What is tinnitus?), vertigo, visual impairment on Aug 20, 2010 from POLAND Additional patient health information: Male patient , 52 years of age, was diagnosed with pemphigus (What is pemphigus?) and. Prednisolone dosage: 0.8 Mg/kg,. During the same period patient was treated with AZATHIOPRINE (150 Mg, Qd) (View Azathioprine Review and Azathioprine Label ), LINCOMYCIN (LINCOMYCIN) (View Lincomycin (lincomycin) Review and Lincomycin (lincomycin) Label ), NADROPARIN CALCIUM (NADROPARIN CALCIUM) (View Nadroparin Calcium (nadroparin Calcium) Review and Nadroparin Calcium (nadroparin Calcium) Label ). Patient was hospitalized.

6955903-0 | Large Intestine Perforation
Adverse event was reported on Aug 19, 2010 by a Female patient taking Prednisolone (View Usage) (Dosage: 20 Mg, Daily) . Location: UNITED KINGDOM , 61 years of age, Patient experienced the following unwanted or unexpected effects: large intestine perforation. During the same period patient was treated with AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), NEOSTIGMINE (45 Mg, 5 X Per Day) (View Neostigmine Review and Neostigmine Label ). Patient was hospitalized.

6941794-0 | Anal Haemorrhage
on Aug 17, 2010 Male patient from UNITED KINGDOM , 66 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Prednisolone (View Usage). Patient had the following side effects: anal haemorrhage. Prednisolone dosage: 5 Mg, 2x/day. During the same period patient was treated with SUNITINIB MALATE (37.5 Mg, 1x/day) (View Sunitinib Malate Review and Sunitinib Malate Label ). Patient was hospitalized.

6937541-9 | Blood Albumin Decreased, Product Colour Issue, Product Quality Issue
on Aug 23, 2010 Male patient from UNITED STATES , weighting 29.40 lb, was diagnosed with nephrotic syndrome and was treated with Prednisolone (View Usage). After Prednisolone was administered, patient had the following side effects: blood albumin decreased, product colour issue, product quality issue. Prednisolone dosage: 5 Ml Twice Daily Po. Patient was hospitalized.

6936294-8 | Haemodialysis, Polyuria, Renal Failure Acute, Tumour Lysis Syndrome
Patient was taking Prednisolone (View Usage). Patient experienced the following unwanted or unexpected effects: haemodialysis, polyuria, renal failure acute, tumour lysis syndrome on Aug 11, 2010 from TURKEY Additional patient health information: Male patient , 19 years of age, . Prednisolone dosage: 64 Mg, Daily. During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ). Patient was hospitalized.

6936265-1 | Reversible Posterior Leukoencephalopathy Syndrome
Adverse event was reported on Aug 13, 2010 by a Female patient taking Prednisolone (View Usage) (Dosage: ) was diagnosed with t-cell lymphoma and. Location: UNITED KINGDOM , 60 years of age, Patient had the following side effects: reversible posterior leukoencephalopathy syndrome. During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ).

6927401-1 | Abdominal Pain, Alanine Aminotransferase Increased, Asthenia, Autoimmune Hepatitis, Back Pain, Blood Bilirubin Increased, Blood Pressure Increased, Carbohydrate Antigen 19-9 Increased, Chromaturia
on Aug 13, 2010 Female patient from UNITED KINGDOM , 60 years of age, weighting 196.2 lb, was diagnosed with prophylaxis and was treated with Prednisolone (View Usage). After Prednisolone was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), alanine aminotransferase increased, asthenia, autoimmune hepatitis, back pain (What is back pain?), blood bilirubin increased, blood pressure increased, carbohydrate antigen 19-9 increased, chromaturia. Prednisolone dosage: . During the same period patient was treated with LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), HEPATITIS A VACCINE (1440df) (View Hepatitis A Vaccine Review and Hepatitis A Vaccine Label ), REVAXIS (View Revaxis Review and Revaxis Label ). Patient was hospitalized.

6922796-7 | Intervertebral Disc Space Narrowing, Intervertebral Discitis, Osteomyelitis, Renal Failure Acute, Spinal Cord Infection, Staphylococcal Infection, Tachycardia
on Aug 03, 2010 Female patient from UNITED KINGDOM , 28 years of age, was diagnosed with eczema (What is eczema?) and was treated with Prednisolone (View Usage). Patient experienced the following unwanted or unexpected effects: intervertebral disc space narrowing, intervertebral discitis, osteomyelitis, renal failure acute, spinal cord infection, staphylococcal infection (What is staphylococcal infection?), tachycardia. Prednisolone dosage: . During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ).

6921675-9 | Chorioretinopathy
Patient was taking Prednisolone (View Usage). Patient had the following side effects: chorioretinopathy on Aug 04, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 43 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and. Prednisolone dosage: . During the same period patient was treated with PREDOCOL (View Predocol Review and Predocol Label ).

6920180-3 | Ataxia, Balance Disorder, Cough, Cytomegalovirus Infection, Cytomegalovirus Myelomeningoradiculitis, Diarrhoea, Haemoglobin Decreased, Neutropenic Sepsis, Pyrexia
Adverse event was reported on Jul 22, 2010 by a Male patient taking Prednisolone (View Usage) (Dosage: ) was diagnosed with plasmablastic lymphoma, prophylaxis, hiv infection (What is hiv infection?) and. Location: UNITED KINGDOM , 50 years of age, After Prednisolone was administered, patient had the following side effects: ataxia (What is ataxia?), balance disorder, cough, cytomegalovirus infection (What is cytomegalovirus infection?), cytomegalovirus myelomeningoradiculitis, diarrhoea, haemoglobin decreased, neutropenic sepsis, pyrexia. During the same period patient was treated with VINCRISTINE (Cyclic) (View Vincristine Review and Vincristine Label ), DOXORUBICIN HCL (Cyclic) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), CYCLOPHOSPHAMIDE (Cyclic) (View Cyclophosphamide Review and Cyclophosphamide Label ), FLUCONAZOLE (50 Mg / Per Day) (View Fluconazole Review and Fluconazole Label ). Patient was hospitalized.

6917635-4 | Abdominal Pain, Alanine Aminotransferase Increased, Asthenia, Autoimmune Hepatitis, Back Pain, Blood Bilirubin Increased, Blood Pressure Increased, Carbohydrate Antigen 19-9 Increased, Chromaturia
on Aug 06, 2010 Female patient from UNITED KINGDOM , 60 years of age, weighting 196.2 lb, was diagnosed with prophylaxis and was treated with Prednisolone (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), alanine aminotransferase increased, asthenia, autoimmune hepatitis, back pain (What is back pain?), blood bilirubin increased, blood pressure increased, carbohydrate antigen 19-9 increased, chromaturia. Prednisolone dosage: . During the same period patient was treated with LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), HEPATITIS A VACCINE (1440df) (View Hepatitis A Vaccine Review and Hepatitis A Vaccine Label ), REVAXIS (View Revaxis Review and Revaxis Label ). Patient was hospitalized.

6916573-0 | Back Pain, Intervertebral Disc Space Narrowing, Intervertebral Discitis, Malaise, Oedema, Osteomyelitis, Pyrexia, Renal Failure Acute, Spinal Cord Infection
on Aug 04, 2010 Female patient from UNITED KINGDOM , 28 years of age, was diagnosed with eczema (What is eczema?) and was treated with Prednisolone (View Usage). Patient had the following side effects: back pain (What is back pain?), intervertebral disc space narrowing, intervertebral discitis, malaise, oedema, osteomyelitis, pyrexia, renal failure acute, spinal cord infection. Prednisolone dosage: . During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ).

6915103-7 | Haematemesis
Patient was taking Prednisolone (View Usage). After Prednisolone was administered, patient had the following side effects: haematemesis on Jul 30, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 22 years of age, weighting 130.1 lb, was diagnosed with crohn's disease (What is crohn's disease?) and. Prednisolone dosage: . During the same period patient was treated with CERAZETTE (View Cerazette Review and Cerazette Label ), CITALOPRAM (View Citalopram Review and Citalopram Label ). Patient was hospitalized.

6914153-4 | Fatigue, Feeling Abnormal, Joint Stiffness, Muscular Weakness
Adverse event was reported on Jul 28, 2010 by a Female patient taking Prednisolone (View Usage) (Dosage: 40 Mg, Daily) was diagnosed with diplopia and. Location: SWEDEN , 70 years of age, Patient experienced the following unwanted or unexpected effects: fatigue, feeling abnormal, joint stiffness, muscular weakness.

6913369-0 | Chorioretinopathy
on Aug 02, 2010 Male patient from , 43 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Prednisolone (View Usage). Patient had the following side effects: chorioretinopathy. Prednisolone dosage: . During the same period patient was treated with PREDNISOLONE SODIUM SULFOBENZOATE (View Prednisolone Sodium Sulfobenzoate Review and Prednisolone Sodium Sulfobenzoate Label ).

6895982-2 | Encephalitis Enteroviral, Gastroenteritis, Hypogammaglobulinaemia, Pneumonia Primary Atypical, Pulmonary Embolism, Sepsis
on Jul 20, 2010 Male patient from UNITED KINGDOM , 75 years of age, was diagnosed with b-cell lymphoma and was treated with Prednisolone (View Usage). After Prednisolone was administered, patient had the following side effects: encephalitis enteroviral, gastroenteritis (What is gastroenteritis?), hypogammaglobulinaemia, pneumonia primary atypical, pulmonary embolism (What is pulmonary embolism?), sepsis (What is sepsis?). Prednisolone dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ). Patient was hospitalized.

6888351-2 | Areflexia, Ataxia, Balance Disorder, Cough, Cytomegalovirus Chorioretinitis, Diarrhoea, Dyspnoea Exertional, Eschar, Febrile Neutropenia
Patient was taking Prednisolone (View Usage). Patient experienced the following unwanted or unexpected effects: areflexia, ataxia (What is ataxia?), balance disorder, cough, cytomegalovirus chorioretinitis, diarrhoea, dyspnoea exertional, eschar, febrile neutropenia on Jul 19, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 50 years of age, was diagnosed with plasmablastic lymphoma, hiv test positive (What is hiv test positive?), infection prophylaxis and. Prednisolone dosage: . During the same period patient was treated with DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), COTRIM (View Cotrim Review and Cotrim Label ), DARUNAVIR (View Darunavir Review and Darunavir Label ), EMTRICITABINE (View Emtricitabine Review and Emtricitabine Label ). Patient was hospitalized.

6879183-X | Haematemesis
Adverse event was reported on Jul 26, 2010 by a Female patient taking Prednisolone (View Usage) (Dosage: ) was diagnosed with crohn's disease (What is crohn's disease?) and. Location: UNITED KINGDOM , 22 years of age, weighting 131.0 lb, Patient had the following side effects: haematemesis. Patient was hospitalized.

6878533-8 | Deep Vein Thrombosis, Pulmonary Embolism
on Jul 16, 2010 Male patient from UNITED KINGDOM , 70 years of age, was diagnosed with prostate cancer (What is prostate cancer?), hypothyroidism, diabetes mellitus, hypertension and was treated with Prednisolone (View Usage). After Prednisolone was administered, patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), pulmonary embolism (What is pulmonary embolism?). Prednisolone dosage: 5 Mg, 2x/day. During the same period patient was treated with SUNITINIB MALATE (37.5 Mg, 1x/day) (View Sunitinib Malate Review and Sunitinib Malate Label ), LEVOTHYROXINE SODIUM (50 Mg, 1x/day) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), METFORMIN (1 G, 1x/day) (View Metformin Review and Metformin Label ), GLICLAZIDE (40 Mg, 1x/day) (View Gliclazide Review and Gliclazide Label ), LISINOPRIL (10 Mg, 1x/day) (View Lisinopril Review and Lisinopril Label ), ASPIRINE (75 Mg, 1x/day) (View Aspirine Review and Aspirine Label ). Patient was hospitalized.

6875945-3 | Hypertension, Ketoacidosis, Kussmaul Respiration, Live Birth, Malaise, Sinus Tachycardia, Vomiting
on Jul 22, 2010 Female patient from UNITED KINGDOM , 22 years of age, was treated with Prednisolone (View Usage). Patient experienced the following unwanted or unexpected effects: hypertension, ketoacidosis, kussmaul respiration, live birth, malaise, sinus tachycardia, vomiting. Prednisolone dosage: . During the same period patient was treated with ERYTHROMYCIN (View Erythromycin Review and Erythromycin Label ). Patient was hospitalized.

6871851-9 | Hypertension, Ketoacidosis, Kussmaul Respiration, Live Birth, Malaise, Sinus Tachycardia, Vomiting
Patient was taking Prednisolone (View Usage). Patient had the following side effects: hypertension, ketoacidosis, kussmaul respiration, live birth, malaise, sinus tachycardia, vomiting on Jul 15, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 22 years of age, . Prednisolone dosage: . During the same period patient was treated with ERYTHROMYCIN (View Erythromycin Review and Erythromycin Label ). Patient was hospitalized.

6870628-8 | Chills, Culture Urine Positive, Infection, Pyelonephritis, Pyrexia
Adverse event was reported on Jul 08, 2010 by a Male patient taking Prednisolone (View Usage) (Dosage: 10 Mg;qd ; 15 Mg;po;qd ; 15 Mg;qd ; 25 Mg;qd ; Po;qd) was diagnosed with kidney transplant rejection and. Location: UNITED STATES , 59 years of age, After Prednisolone was administered, patient had the following side effects: chills, culture urine positive, infection (What is infection?), pyelonephritis, pyrexia. During the same period patient was treated with MYCOPHENOLATE MOFETIL (750 Mg;po;bid ; 1000 Mg;po;bid ; 1000 Mg;qd ; 1000 Mg;qd) (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), CYCLOSPORINE (75 Mg;po;bid ; 150 Mg;po;bid ; 75 Mg;bid;po) (View Cyclosporine Review and Cyclosporine Label ). Patient was hospitalized.

6862041-4 | Cytomegalovirus Infection, Febrile Neutropenia
on Jul 07, 2010 Male patient from UNITED KINGDOM , 50 years of age, was diagnosed with plasmablastic lymphoma, prophylaxis, hiv infection (What is hiv infection?) and was treated with Prednisolone (View Usage). Patient experienced the following unwanted or unexpected effects: cytomegalovirus infection (What is cytomegalovirus infection?), febrile neutropenia. Prednisolone dosage: . During the same period patient was treated with VINCRISTINE SULFATE (View Vincristine Sulfate Review and Vincristine Sulfate Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), FLUCONAZOLE (50 Mg, Qd) (View Fluconazole Review and Fluconazole Label ), ACYCLOVIR (400 Mg, Bid) (View Acyclovir Review and Acyclovir Label ), AZITHROMYCIN (1250 Mg, 1/week) (View Azithromycin Review and Azithromycin Label ), COTRIM (960 Mg, Qd) (View Cotrim Review and Cotrim Label ), TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ).

6857950-6 | Chills, Culture Urine Positive, Pyelonephritis
on Jun 29, 2010 Male patient from UNITED STATES , 59 years of age, was diagnosed with kidney transplant rejection and was treated with Prednisolone (View Usage). Patient had the following side effects: chills, culture urine positive, pyelonephritis. Prednisolone dosage: 10 Mg; Qd, 15 Mg; Po;qd, 25 Mg; Qd; Po. During the same period patient was treated with MYCOPHENOLATE MOFETIL (750 Mg; Po;bid,1000 Mg; Po;bid, 1000 Mg; Qd) (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), CYCLOSPORINE (75 Mg; Po;bid, 150 Mg; Po;bid) (View Cyclosporine Review and Cyclosporine Label ). Patient was hospitalized.

6857498-9 | Hepatic Neoplasm Malignant
Patient was taking Prednisolone (View Usage). After Prednisolone was administered, patient had the following side effects: hepatic neoplasm malignant on Jul 08, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 37 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and. Prednisolone dosage: Unk. During the same period patient was treated with AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), AMINOSALICYLIC ACID (Unk) (View Aminosalicylic Acid Review and Aminosalicylic Acid Label ). Patient was hospitalized.

6857495-3 | Hepatic Neoplasm Malignant
Adverse event was reported on Jul 08, 2010 by a Male patient taking Prednisolone (View Usage) (Dosage: Unk) was diagnosed with crohn's disease (What is crohn's disease?) and. Location: UNITED KINGDOM , 25 years of age, Patient experienced the following unwanted or unexpected effects: hepatic neoplasm malignant. During the same period patient was treated with AZATHIOPRINE (Unk) (View Azathioprine Review and Azathioprine Label ), INFLIXIMAB (Unk) (View Infliximab Review and Infliximab Label ). Patient was hospitalized.

6857493-X | Hepatic Neoplasm Malignant
on Jul 08, 2010 Female patient from UNITED KINGDOM , 43 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Prednisolone (View Usage). Patient had the following side effects: hepatic neoplasm malignant. Prednisolone dosage: Unk. During the same period patient was treated with AZATHIOPRINE (Unk) (View Azathioprine Review and Azathioprine Label ).

6856841-4 | Hypertension, Ketoacidosis, Kussmaul Respiration, Malaise, Sinus Tachycardia, Vomiting
on Jul 14, 2010 Female patient from UNITED KINGDOM , 22 years of age, was diagnosed with asthma (What is asthma?) and was treated with Prednisolone (View Usage). After Prednisolone was administered, patient had the following side effects: hypertension, ketoacidosis, kussmaul respiration, malaise, sinus tachycardia, vomiting. Prednisolone dosage: . During the same period patient was treated with ERYTHROMYCIN (View Erythromycin Review and Erythromycin Label ). Patient was hospitalized.

6856208-9 | Csf Pressure Increased, Headache, Meningitis Cryptococcal
Patient was taking Prednisolone (View Usage). Patient experienced the following unwanted or unexpected effects: csf pressure increased, headache (What is headache?), meningitis cryptococcal on Jul 12, 2010 from NETHERLANDS Additional patient health information: Female patient , 42 years of age, was diagnosed with anaemia haemolytic autoimmune and. Prednisolone dosage: . Patient was hospitalized.

6856206-5 | Infertility Female
Adverse event was reported on Jul 14, 2010 by a Female patient taking Prednisolone (View Usage) (Dosage: ) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: UNITED KINGDOM , 39 years of age, Patient had the following side effects: infertility female. During the same period patient was treated with DICLOFENAC SODIUM (View Diclofenac Sodium Review and Diclofenac Sodium Label ).

6846667-X | Bronchiectasis, Cushingoid, Malaise, Metabolic Disorder, Pancytopenia
on Jul 02, 2010 Female patient from UNITED KINGDOM , 68 years of age, was diagnosed with interstitial lung disease and was treated with Prednisolone (View Usage). After Prednisolone was administered, patient had the following side effects: bronchiectasis, cushingoid, malaise, metabolic disorder (What is metabolic disorder?), pancytopenia. Prednisolone dosage: ( 30 Mg Qd Oral). During the same period patient was treated with AZATHIOPRINE ((50 Mg Tid Oral), (50 Mg Bid Oral), (5 Mg Qd Oral)) (View Azathioprine Review and Azathioprine Label ).

6840662-2 | Oedema Peripheral
on Jul 05, 2010 Male patient from UNITED KINGDOM , 74 years of age, weighting 138.9 lb, was diagnosed with prostate cancer (What is prostate cancer?), decreased appetite, pain (What is pain?), prophylaxis and was treated with Prednisolone (View Usage). Patient experienced the following unwanted or unexpected effects: oedema peripheral. Prednisolone dosage: 5 Mg, 2x/day. During the same period patient was treated with SUNITINIB MALATE (37.5 Mg, 1x/day) (View Sunitinib Malate Review and Sunitinib Malate Label ), PARACETAMOL (Unk) (View Paracetamol Review and Paracetamol Label ), OMEPRAZOLE (Unk) (View Omeprazole Review and Omeprazole Label ), OXYCONTIN (Unk) (View Oxycontin Review and Oxycontin Label ), CLEXANE (Unk) (View Clexane Review and Clexane Label ). Patient was hospitalized.

6836027-X | Condition Aggravated, Dysphagia, Erythema Multiforme, Fatigue, Lymphocyte Transformation Test Positive, Lymphocytic Infiltration, Mouth Ulceration, Pyrexia
Patient was taking Prednisolone (View Usage). Patient had the following side effects: condition aggravated, dysphagia, erythema multiforme, fatigue, lymphocyte transformation test positive, lymphocytic infiltration, mouth ulceration, pyrexia on Jul 05, 2010 from JAPAN Additional patient health information: Male patient , 16 years of age, was diagnosed with oral herpes and. Prednisolone dosage: . During the same period patient was treated with VALACYCLOVIR (1000mg Per Day) (View Valacyclovir Review and Valacyclovir Label ). Patient was hospitalized.